Selected research
Industry Research
Cisatracurium Besylate Injection Industry Research Report 2026
Market perspective
The global Cisatracurium Besylate Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cisatracurium Besylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cisatracurium Besylate Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cisatracurium Besylate Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cisatracurium Besylate Injection include Meitheal Pharmaceuticals, AbbVie, Fresenius Kabi, Pfizer, Jiangsu Singchn, Sandoz, Shanghai Sino Biopharma, Shanghai Hengrui Pharmaceutical and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cisatracurium Besylate Injection market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cisatracurium Besylate Injection Market by Company
Meitheal Pharmaceuticals
AbbVie
Fresenius Kabi
Pfizer
Jiangsu Singchn
Sandoz
Shanghai Sino Biopharma
Shanghai Hengrui Pharmaceutical
Teva
Xianju Pharma
Cisatracurium Besylate Injection Segment by Type
2 mg/mL
5 mg/mL
10 mg/mL
Cisatracurium Besylate Injection Segment by Application
Clinics
Hospital
Recovery Center
Cisatracurium Besylate Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cisatracurium Besylate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cisatracurium Besylate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cisatracurium Besylate Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cisatracurium Besylate Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cisatracurium Besylate Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cisatracurium Besylate Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 2 mg/mL
- 5 mg/mL
- 10 mg/mL
Applications
- Clinics
- Hospital
- Recovery Center
Companies covered
- Meitheal Pharmaceuticals
- AbbVie
- Fresenius Kabi
- Pfizer
- Jiangsu Singchn
- Sandoz
- Shanghai Sino Biopharma
- Shanghai Hengrui Pharmaceutical
- Teva
- Xianju Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cisatracurium Besylate Injection Market Size (2021-2032)
- 2.2.2 Global Cisatracurium Besylate Injection Sales (2021-2032)
- 2.2.3 Global Cisatracurium Besylate Injection Market Average Price (2021-2032)
- 2.3 Cisatracurium Besylate Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 2 mg/mL
- 2.3.3 5 mg/mL
- 2.3.4 10 mg/mL
- 2.4 Cisatracurium Besylate Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinics
- 2.4.3 Hospital
- 2.4.4 Recovery Center
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cisatracurium Besylate Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cisatracurium Besylate Injection Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Cisatracurium Besylate Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Cisatracurium Besylate Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Cisatracurium Besylate Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cisatracurium Besylate Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cisatracurium Besylate Injection, Product Type & Application
- 3.8 Global Manufacturers of Cisatracurium Besylate Injection, Established Date
- 3.9 Global Cisatracurium Besylate Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Meitheal Pharmaceuticals
- 4.1.1 Meitheal Pharmaceuticals Company Information
- 4.1.2 Meitheal Pharmaceuticals Business Overview
- 4.1.3 Meitheal Pharmaceuticals Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Meitheal Pharmaceuticals Cisatracurium Besylate Injection Product Portfolio
- 4.1.5 Meitheal Pharmaceuticals Recent Developments
- 4.2 AbbVie
- 4.2.1 AbbVie Company Information
- 4.2.2 AbbVie Business Overview
- 4.2.3 AbbVie Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 AbbVie Cisatracurium Besylate Injection Product Portfolio
- 4.2.5 AbbVie Recent Developments
- 4.3 Fresenius Kabi
- 4.3.1 Fresenius Kabi Company Information
- 4.3.2 Fresenius Kabi Business Overview
- 4.3.3 Fresenius Kabi Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Fresenius Kabi Cisatracurium Besylate Injection Product Portfolio
- 4.3.5 Fresenius Kabi Recent Developments
- 4.4 Pfizer
- 4.4.1 Pfizer Company Information
- 4.4.2 Pfizer Business Overview
- 4.4.3 Pfizer Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pfizer Cisatracurium Besylate Injection Product Portfolio
- 4.4.5 Pfizer Recent Developments
- 4.5 Jiangsu Singchn
- 4.5.1 Jiangsu Singchn Company Information
- 4.5.2 Jiangsu Singchn Business Overview
- 4.5.3 Jiangsu Singchn Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Jiangsu Singchn Cisatracurium Besylate Injection Product Portfolio
- 4.5.5 Jiangsu Singchn Recent Developments
- 4.6 Sandoz
- 4.6.1 Sandoz Company Information
- 4.6.2 Sandoz Business Overview
- 4.6.3 Sandoz Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sandoz Cisatracurium Besylate Injection Product Portfolio
- 4.6.5 Sandoz Recent Developments
- 4.7 Shanghai Sino Biopharma
- 4.7.1 Shanghai Sino Biopharma Company Information
- 4.7.2 Shanghai Sino Biopharma Business Overview
- 4.7.3 Shanghai Sino Biopharma Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Shanghai Sino Biopharma Cisatracurium Besylate Injection Product Portfolio
- 4.7.5 Shanghai Sino Biopharma Recent Developments
- 4.8 Shanghai Hengrui Pharmaceutical
- 4.8.1 Shanghai Hengrui Pharmaceutical Company Information
- 4.8.2 Shanghai Hengrui Pharmaceutical Business Overview
- 4.8.3 Shanghai Hengrui Pharmaceutical Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Shanghai Hengrui Pharmaceutical Cisatracurium Besylate Injection Product Portfolio
- 4.8.5 Shanghai Hengrui Pharmaceutical Recent Developments
- 4.9 Teva
- 4.9.1 Teva Company Information
- 4.9.2 Teva Business Overview
- 4.9.3 Teva Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Teva Cisatracurium Besylate Injection Product Portfolio
- 4.9.5 Teva Recent Developments
- 4.10 Xianju Pharma
- 4.10.1 Xianju Pharma Company Information
- 4.10.2 Xianju Pharma Business Overview
- 4.10.3 Xianju Pharma Cisatracurium Besylate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Xianju Pharma Cisatracurium Besylate Injection Product Portfolio
- 4.10.5 Xianju Pharma Recent Developments
5 Global Cisatracurium Besylate Injection Market Scenario by Region
- 5.1 Global Cisatracurium Besylate Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cisatracurium Besylate Injection Sales by Region: 2021-2032
- 5.2.1 Global Cisatracurium Besylate Injection Sales by Region: 2021-2026
- 5.2.2 Global Cisatracurium Besylate Injection Sales by Region: 2027-2032
- 5.3 Global Cisatracurium Besylate Injection Revenue by Region: 2021-2032
- 5.3.1 Global Cisatracurium Besylate Injection Revenue by Region: 2021-2026
- 5.3.2 Global Cisatracurium Besylate Injection Revenue by Region: 2027-2032
- 5.4 North America Cisatracurium Besylate Injection Market Facts & Figures by Country
- 5.4.1 North America Cisatracurium Besylate Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cisatracurium Besylate Injection Sales by Country (2021-2032)
- 5.4.3 North America Cisatracurium Besylate Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Cisatracurium Besylate Injection Market Facts & Figures by Country
- 5.5.1 Europe Cisatracurium Besylate Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cisatracurium Besylate Injection Sales by Country (2021-2032)
- 5.5.3 Europe Cisatracurium Besylate Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Cisatracurium Besylate Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cisatracurium Besylate Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cisatracurium Besylate Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cisatracurium Besylate Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cisatracurium Besylate Injection Market Facts & Figures by Country
- 5.7.1 South America Cisatracurium Besylate Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cisatracurium Besylate Injection Sales by Country (2021-2032)
- 5.7.3 South America Cisatracurium Besylate Injection Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Cisatracurium Besylate Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cisatracurium Besylate Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cisatracurium Besylate Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cisatracurium Besylate Injection Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Cisatracurium Besylate Injection Sales by Type (2021-2032)
- 6.1.1 Global Cisatracurium Besylate Injection Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Cisatracurium Besylate Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Cisatracurium Besylate Injection Revenue by Type (2021-2032)
- 6.2.1 Global Cisatracurium Besylate Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cisatracurium Besylate Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Cisatracurium Besylate Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cisatracurium Besylate Injection Sales by Application (2021-2032)
- 7.1.1 Global Cisatracurium Besylate Injection Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Cisatracurium Besylate Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Cisatracurium Besylate Injection Revenue by Application (2021-2032)
- 7.2.1 Global Cisatracurium Besylate Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cisatracurium Besylate Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Cisatracurium Besylate Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cisatracurium Besylate Injection Value Chain Analysis
- 8.1.1 Cisatracurium Besylate Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cisatracurium Besylate Injection Production Mode & Process
- 8.2 Cisatracurium Besylate Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cisatracurium Besylate Injection Distributors
- 8.2.3 Cisatracurium Besylate Injection Customers
9 Global Cisatracurium Besylate Injection Analyzing Market Dynamics
- 9.1 Cisatracurium Besylate Injection Industry Trends
- 9.2 Cisatracurium Besylate Injection Industry Drivers
- 9.3 Cisatracurium Besylate Injection Industry Opportunities and Challenges
- 9.4 Cisatracurium Besylate Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst